22nd Century Group Inc. (XXII)

1.86
0.03 1.59
AMEX : Health Technology
Prev Close 1.89
Open 1.89
Day Low/High 1.84 / 1.89
52 Wk Low/High 1.12 / 3.29
Volume 393.22K
Avg Volume 1.16M
Exchange AMEX
Shares Outstanding 125.66M
Market Cap 241.27M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

22nd Century Group Appoints Cliff Fleet Chief Executive Officer

22nd Century Group Appoints Cliff Fleet Chief Executive Officer

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced today that the Company has appointed Clifford B.

22nd Century Group Announces Conference Call To Provide Business Update

22nd Century Group Announces Conference Call To Provide Business Update

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced today that the Company will provide a business...

22nd Century Group CEO To Step Down

22nd Century Group CEO To Step Down

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced today that President and Chief Executive...

First Week Of XXII September 20th Options Trading

First Week Of XXII September 20th Options Trading

Investors in 22nd Century Group Inc saw new options become available this week, for the September 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XXII options chain for the new September 20th contracts and identified the following call contract of particular interest.

FDA Accepts And Files 22nd Century Group's Modified Risk Tobacco Product Application For VLN™ Cigarettes

FDA Accepts And Files 22nd Century Group's Modified Risk Tobacco Product Application For VLN™ Cigarettes

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, announced today that the U.

Interesting XXII Call Options For August 16th

Interesting XXII Call Options For August 16th

Investors in 22nd Century Group Inc saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XXII options chain for the new August 16th contracts and identified the following call contract of particular interest.

22nd Century Group Appoints Michael J. Zercher As Chief Operating Officer

22nd Century Group Appoints Michael J. Zercher As Chief Operating Officer

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis research, announced today the appointment of Michael J.

22nd Century Files 2019 First Quarter Report And Announces Conference Call To Provide Business Update

22nd Century Files 2019 First Quarter Report And Announces Conference Call To Provide Business Update

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today that the Company filed its 2019 First Quarter Report on...

22nd Century's Pre-Market Tobacco Application For VLN™ Cigarettes Advances With Completed FDA Inspection

22nd Century's Pre-Market Tobacco Application For VLN™ Cigarettes Advances With Completed FDA Inspection

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today that last week the U.

June 21st Options Now Available For 22nd Century Group (XXII)

June 21st Options Now Available For 22nd Century Group (XXII)

Investors in 22nd Century Group Inc saw new options become available today, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XXII options chain for the new June 21st contracts and identified the following call contract of particular interest.

Grossly Misleading "Short And Distort" Article Wrongfully Attempts To Dupe 22nd Century Group Shareholders

Grossly Misleading "Short And Distort" Article Wrongfully Attempts To Dupe 22nd Century Group Shareholders

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, today commented on a grossly misleading article published...

22nd Century Group Hires Former Imperial Brands Head Of Regulatory Science

22nd Century Group Hires Former Imperial Brands Head Of Regulatory Science

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today the hiring of John D.

22nd Century Announces Exclusive Worldwide Agreement With KeyGene For Genetic Development Of Hemp/Cannabis

22nd Century Announces Exclusive Worldwide Agreement With KeyGene For Genetic Development Of Hemp/Cannabis

22nd Century Group, Inc. (NYSE American:  XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today that the Company has entered into a worldwide...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: FGEN, GOLF, HNGR, MO, NOMD, NRE, PYX Downgrades: ANIK, BDC, CRHM, ETM, RUN, SEAS, TKC, WBA, XXII Initiations: ADT, EYE Read on to get TheStreet Quant Ratings' detailed report:

22nd Century Group Issues Annual Letter To Shareholders

22nd Century Group Issues Annual Letter To Shareholders

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today that the Company has issued its annual letter to...

Lifshitz & Miller LLP Announces Investigation Of 22nd Century Group, Activision Blizzard, Inc., Astec Industries, Inc., Avon Products, Inc., Axogen, Inc., Everquote Inc. And Health Insurance Innovations, Inc.

Lifshitz & Miller LLP Announces Investigation Of 22nd Century Group, Activision Blizzard, Inc., Astec Industries, Inc., Avon Products, Inc., Axogen, Inc., Everquote Inc. And Health Insurance Innovations, Inc.

NEW YORK, March 22, 2019 /PRNewswire/ -- 22 nd Century Group (XXII) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that  XXII's stock was prone to manipulation through paid stock...

First Week Of XXII May 17th Options Trading

First Week Of XXII May 17th Options Trading

Investors in 22nd Century Group Inc saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XXII options chain for the new May 17th contracts and identified the following call contract of particular interest.

22nd Century Files 2018 Annual Report And Announces Conference Call To Provide Business Update

22nd Century Files 2018 Annual Report And Announces Conference Call To Provide Business Update

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today that the Company filed its 2018 Annual Report on Form...

Interesting XXII Put And Call Options For October 18th

Interesting XXII Put And Call Options For October 18th

Investors in 22nd Century Group Inc saw new options begin trading this week, for the October 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Glancy Prongay & Murray LLP Reminds Investors Of The Deadline In The Class Action Lawsuit Against 22nd Century Group, Inc. (XXII)

Glancy Prongay & Murray LLP Reminds Investors Of The Deadline In The Class Action Lawsuit Against 22nd Century Group, Inc. (XXII)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the March 22, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased 22nd Century Group, Inc.

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against 22nd Century Group, Inc. And Encourages Investors With Losses In Excess Of $500,000 To Contact The Firm

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against 22nd Century Group, Inc. And Encourages Investors With Losses In Excess Of $500,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against 22nd Century Group, Inc.

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against 22nd Century Group, Inc. And Encourages Investors With Losses In Excess Of $500,000 To Contact The Firm

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against 22nd Century Group, Inc. And Encourages Investors With Losses In Excess Of $500,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against 22nd Century Group, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against 22nd Century Group, Inc. - XXII

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against 22nd Century Group, Inc. - XXII

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of 22nd Century Group, Inc.

First Week Of XXII February 15th Options Trading

First Week Of XXII February 15th Options Trading

Investors in 22nd Century Group Inc saw new options begin trading this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XXII options chain for the new February 15th contracts and identified one put and one call contract of particular interest.

22nd Century Files Modified Risk Tobacco Product (MRTP) Application With The FDA For The Company's Very Low Nicotine Content Cigarettes

22nd Century Files Modified Risk Tobacco Product (MRTP) Application With The FDA For The Company's Very Low Nicotine Content Cigarettes

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, today submitted a Modified Risk Tobacco Product (MRTP) application with the U.

22nd Century's Low-THC Cannabis Sativa L. Research Activities Receive Legislative Boost

22nd Century's Low-THC Cannabis Sativa L. Research Activities Receive Legislative Boost

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and hemp/cannabis research, announced today that the 2018 Farm Bill will greatly enhance the Company's research activities around low-THC...

22nd Century Files Premarket Tobacco Application (PMTA) With The FDA

22nd Century Files Premarket Tobacco Application (PMTA) With The FDA

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, today submitted a Premarket Tobacco Application (PMTA) with the U.

TheStreet Quant Rating: D+ (Sell)